Inhibitory effects of plant phenolic compounds on enzymatic and cytotoxic activities induced by a snake venom phospholipase A2;Efectos inhibitorios de compuestos fenólicos de plantas sobre la actividad enzimática y citotoxica inducida por una fosfolipasa A2 de veneno de serpiente

Vitae

Volumn 18, Issue 3, 2011, Pages 295-304

  PereañEZ, Jaime A ^a   NúÑEZ, Vitelbina ^a   PatiñO, Arley C ^a   Mónica, LondoñO ^a   Quintana, Juan C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Local tissue damage; Molecular docking; Phenolic compounds; Phospholipase a2; Snake bite

Indexed keywords

CAFFEIC ACID; EPIGALLOCATECHIN GALLATE; FERULIC ACID; GALLIC ACID; GALLIC ACID PROPYL ESTER; PHENOL DERIVATIVE; PHOSPHOLIPASE A2; SNAKE VENOM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOTOXICITY; DRUG PROTEIN BINDING; EGG YOLK; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; MOLECULAR DOCKING; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 82755177579     PISSN: 01214004     EISSN: 21452660     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Simpson ID, Norris RL. The global snakebite crisis-a public health issue misunderstood, not neglected. Wild Environ Med. 2009 Mar; 20 (1): 43-56.
2. Markland FS. Snake Venoms. Drugs. 1997; 54 (Suppl 3): 1-10.
3. Six DA, Dennis EA. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim Biophys Acta. 2000 Oct 31; 1988 (1-2): 1-19.
4. Kini RM. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon. 2003 Dec; 42 (8): 827-840.
5. Gutiérrez JM, Ownby C. Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. Toxicon. 2003 Dec 15; 42 (8): 915-931.
6. Soares AM, Giglio JR. Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties. Toxicon. 2003 Dec; 42 (8): 855-68.
7. Bon C. The serum - therapie was discovered 100 years ago. Toxicon. 1996 Feb 1; 34 (2): 142-143.
8. Gutiérrez JM, León G, Rojas G, Lomonte B, Rucavado A, Chaves F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon. 1998 Nov; 36 (11): 1529-1538.
9. Martz W. Plants with a reputation against snake bite. Toxicon. 1992 Oct; 30 (10): 1131-1142.
10. Otero R, Nuñez V, Jiménez S, Fonnegra R, Osorio R, Garcia ME, Diaz A. Snakebites and ethnobotany in the northwest region of Colombia. Part II: Neutralization of lethal and enzymatic effects of Bothrops atrox venom. J Ethnopharmacol. 2000 Aug; 71 (3): 505-511.
11. Coe FG, Anderson GJ. Snakebite ethnopharmacopoeia of eastern Nicaragua. J Ethnopharmacol. 2005 Jan 4; 96 (1-2): 303-323.
12. Núñez V, Castro V, Murillo R, Ponce-Soto LA, Merforf I. Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle. Phytochemistry. 2005 May; 66 (9): 1017-1025.
13. Soares AM, Ticli FK, Marcussi S, Lourenço MV, Januário AH, Sampaio SV, et al. Medicinal Plants with Inhibitory Properties Against Snake Venoms. Curr Med Chem. 2005; 12 (22): 2625-2641.
14. Marcussi S, Sant'Ana CD, Oliveira CZ, Rueda AQ, Menaldo DL, Beleboni RO, et al. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Curr Top Med Chem. 2007; 7 (8): 743-756.
15. Pithayanukul P, Ruenraroengsak P, Bavovada R, Pakmanee N, Suttisri R, Saen-oon S. Inhibition of Naja kaouthia venom activities by plant polyphenols. J Ethnopharmacol. 2005 Mar 21; 97 (3): 527-533.
16. Leanpolchareanchai J, Pithayanukul P, Bavovada R, Saparpakorn P. Molecular docking studies and anti-enzymatic activities of Thai mango seed kernel extract against snake venoms. Molecules. 2009 Aug 27; 14 (4): 1404-1422.
17. Ticli FK, Hage LIS, Cambraia RS, Pereira PS, Magro ÂJ, Fontes MRM, et al. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction. Toxicon. 2005 Sep 1; 46 (3): 318-327.
18. Haslam E. Natural polyphenols (Vegetable tannins) as drugs: Possible modes of action. J Nat Prod. 1996 Feb; 59 (2): 205-215.
19. Pithayanukul P, Ruenraroengsak P, Bavovada, R, Pakmanee N, Suttisri, R. In Vitro. Investigation of the Protective Effects of Tannic Acid Against the Activities of Naja kaouthia. Venom. Pharm Biol. 2007 Feb 1; 45 (2): 94-97.
20. Kuppusamy UR, Das NP. Protective effects of tannic acid and related natural compounds on Crotalus adamenteus subcutaneous poisoning in mice. Pharmacol Toxicol. 1993 Apr-May; 72 (4-5): 290-295.
21. Pereañez JA, Núñez V, Huancahuire-Vega S, Marangoni S, Ponce-Soto LA. Biochemical and biological characterization of a PLA2 from crotoxin complex of Crotalus durissus cumanensis. Toxicon. 2009 Apr; 53 (5): 534-542.
22. Dole VP. A relation between non esterified-fatty acids in plasma and the metabolisms of glucose. J Clin Invest. 1956 Feb; 35 (2): 150-154.
23. Holzer, M, Mackessy, SP. An aqueous endpoint assay of snake venom phospholipase A2. Toxicon. 1996 Oct; 34 (10): 1149-1155.
24. Lomonte B, Angulo Y, Rufini S, Cho W, Giglio JR, Ohno M, et al. Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon. 1999 Jan; 37 (1): 145-158.
25. Thomsen R, Christensen MH. MolDock: a new technique for high accuracy molecular docking. J Med Chem. 2006 Apr 29; 49 (11): 3315-3321.
26. Murakami M, Kudo T. Secretory phospholipase A2. Biol Pharm Bull. 2004 Aug 10; 27 (8): 1158-1164.
27. Habermann E, Breithaupt H. The crotoxin complex: an example of biochemical and pharmacological protein complementation. Toxicon 1978; 16 (1): 19-30.
28. Hendon RA, Fraenkel-Conrat H. Biological roles of the two components of crotoxin. Proc Natl Acad Sci USA. 1971 Jul; 68 (7): 1560-1563.
29. Meier J, White J (Ed.). Handbook of Clinical Toxicology of Animal, Venoms and Poisons. Boca Raton, FL: CRC Press; 1995. Fan HW, Cardoso JLC. Clinical toxicology of snakebite in South America; p. 667-688.
30. Kini, R (Ed.). Venom phospholipase A2 enzymes: structure, function and mechanism. Chichester: John Wiley & Sons; 1997. Scott D. Phospholipase A2: structure and catalytic properties; p. 97-128.
31. Teixeira CF, Landucci EC, Antunes E, Chacur M, Cury Y. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon. 2003 Dec 15; 42 (8): 947-962.
32. Montecucco C, Gutiérrez JM, Lomonte B. Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell Mol Life Sci. 2008; 65 (18): 2897-2912.
33. Bon, C, Goyffon, M (Eds.). Envenomings and Their Treatments. Lyon: Fondation Marcel Mérieux; 1996. Warrell, DA. Clinical features of envenoming by snake bites; p. 63-76.
34. Pithayanukul P, Leanpolchareanchai J, Bavovada R. Inhibitory effect of tea polyphenols on local tissue damage induced by snake venoms. Phytother Res. 2010 Jan; 24 (Suppl 1): S56-S2.
35. Pithayanukul P, Leanpolchareanchai J, Saparpakorn P. Molecular docking studies and anti-snake venom metalloproteinase activity of Thai mango seed kernel extract. Molecules. 2009 Aug 27; 14 (9): 3198-3213.
36. Nirmal N, Praba GO, Velmurugan D. Modeling studies on phospholipase A2-inhibitor complexes. Indian J Biochem Bio. 2008 Aug; 45 (4): 256-262.
37. Da Silva SL, Calgarotto AK, Maso V, Damico DCS, Baldasso P, Veber CL, et al. Molecular modeling and inhibition of phosp holipase A2 by polyhydro xy phenolic compounds. Eur J Med Chem. 2009 Jan; 44 (1): 312-321.
38. Berg OG, Gelb MH, Tsai MD, Jain MK. Interfacial enzymology: the secreted phospholipase A2-paradigm. Chem Rev. 2001 Sep; 101 (9): 2613-2654.
39. Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 2000 Oct 5; 43 (20): 3714-3717.
40. Doerksen RJ, Prasanna S. Topological Polar Surface Area: A Useful Descriptor in 2D-QSAR. Curr Med Chem. 2009; 16 (1): 21-41
41. Lindahl M, Tagesson C. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 1997 Jun; 21 (3): 347-356.
42. Chandra V, Jasti J, Kaur P, Betzel Ch, Srinivasan A, Singh TP. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. J Mol Biol. 2002 Jul 5; 320 (2): 215-222.
43. Chandra V, Jasti J, Kaur P, Srinivasan A, Betzel Ch, Singh TP. Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure. Biochemistry. 2002 Sep 10; 41 (36): 10914-10919.
44. Mors WB, Nascimento MC, Pereira BM, Pereira NA. Plant natural products active against snakebite-the molecular approach. Phytochemistry. 2000 Nov; 55 (6): 627-642.